Susan Molineaux - Net Worth and Insider Trading
Susan Molineaux Net Worth
The estimated net worth of Susan Molineaux is at least $4 dollars as of 2024-12-27. Susan Molineaux is the PRESIDENT & CEO of Calithera Biosciences Inc and owns about 37,859 shares of Calithera Biosciences Inc (CALA) stock worth over $4. Susan Molineaux is also the Director of Geron Corp and owns about 0 shares of Geron Corp (GERN) stock worth over $0. Details can be seen in Susan Molineaux's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan Molineaux has not made any transactions after 2023-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susan Molineaux
Susan Molineaux Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan Molineaux owns 5 companies in total, including Geron Corp (GERN) , Theravance Biopharma Inc (TBPH) , and Calithera Biosciences Inc (CALA) among others .
Click here to see the complete history of Susan Molineaux’s form 4 insider trades.
Insider Ownership Summary of Susan Molineaux
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GERN | Geron Corp | 2023-05-01 | director |
| TBPH | Theravance Biopharma Inc | 2015-04-22 | director |
| CALA | Calithera Biosciences Inc | 2021-11-10 | director & PRESIDENT AND CEO |
 | | 2021-06-17 | director |
| | 2023-06-08 | director |
Susan Molineaux Latest Holdings Summary
Susan Molineaux currently owns a total of 2 stocks. Among these stocks, Susan Molineaux owns 37,859 shares of Calithera Biosciences Inc (CALA) as of November 10, 2021, with a value of $4 and a weighting of 100%. Susan Molineaux also owns 0 shares of Geron Corp (GERN) as of May 1, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Susan Molineaux
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CALA | Calithera Biosciences Inc | 2021-11-10 | 37,859 | 0.00 | 4 |
| GERN | Geron Corp | 2023-05-01 | 0 | 3.31 | 0 |
Holding Weightings of Susan Molineaux
Susan Molineaux Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan Molineaux has made a total of 1 transactions in Calithera Biosciences Inc (CALA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Calithera Biosciences Inc is the acquisition of 5,000 shares on November 10, 2021, which cost Susan Molineaux around $85,000.
According to the SEC Form 4 filings, Susan Molineaux has made a total of 1 transactions in Geron Corp (GERN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Geron Corp is the sale of 35,000 shares on May 1, 2023, which brought Susan Molineaux around $86,800.
Insider Trading History of Susan Molineaux
- 1
Susan Molineaux Trading Performance
GuruFocus tracks the stock performance after each of Susan Molineaux's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan Molineaux is -24.58%. GuruFocus also compares Susan Molineaux's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan Molineaux within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Susan Molineaux's insider trading performs compared to the benchmark.
Performance of Susan Molineaux
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.91 | | | | | |
| Relative Return to S&P 500(%) | -1.28 | | | | | |
Susan Molineaux Ownership Network
Susan Molineaux Owned Company Details
What does Geron Corp do?
Who are the key executives at Geron Corp?
Susan Molineaux is the director of Geron Corp. Other key executives at Geron Corp include EVP & Technical Operations Andrew J Grethlein , EVP & Corp Strategy & CCO Anil Kapur , and EVP & Chief Medical Officer Faye Feller .
Geron Corp (GERN) Insider Trades Summary
Over the past 18 months, Susan Molineaux made no insider transaction in Geron Corp (GERN). Other recent insider transactions involving Geron Corp (GERN) include a net sale of 674,348 shares made by Andrew J Grethlein , a net sale of 600,000 shares made by John A Scarlett , and a net sale of 421,875 shares made by Anil Kapur .
In summary, during the past 3 months, insiders sold 0 shares of Geron Corp (GERN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,984,123 shares of Geron Corp (GERN) were sold and 13,186 shares were bought by its insiders, resulting in a net sale of 1,970,937 shares.
Geron Corp (GERN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Geron Corp Insider Transactions
Susan Molineaux Mailing Address
Above is the net worth, insider trading, and ownership report for Susan Molineaux. You might contact Susan Molineaux via mailing address: C/o Calithera Biosciences, Inc., 343 Oyster Point Blvd., Suite 200, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
